These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 4427494

  • 21. Editorial: Reserpine and breast cancer.
    Can Med Assoc J; 1975 Jan 25; 112(2):129. PubMed ID: 1111862
    [No Abstract] [Full Text] [Related]

  • 22. More on the subject of reserpine.
    Gunby P.
    JAMA; 1979 Jun 15; 241(24):2587, 2591. PubMed ID: 439346
    [No Abstract] [Full Text] [Related]

  • 23. [Editorial: Is reserpine medication associated with increased risk of breast cancer?].
    Modan B.
    Harefuah; 1975 Jan 15; 88(2):81-3. PubMed ID: 1112561
    [No Abstract] [Full Text] [Related]

  • 24. [Reserpine and breast cancer].
    Teppo L, Hakama M.
    Duodecim; 1974 Jan 15; 90(23):1637-41. PubMed ID: 4459070
    [No Abstract] [Full Text] [Related]

  • 25. Reserpine and breast cancer in the Hypertension Detection and Follow-Up Program.
    Curb JD, Hardy RJ, Labarthe DR, Borhani NO, Taylor JO.
    Hypertension; 1982 Jan 15; 4(2):307-11. PubMed ID: 7040229
    [Abstract] [Full Text] [Related]

  • 26. Reserpine: a tragic victim of myths, marketing, and fashionable prescribing.
    Fraser HS.
    Clin Pharmacol Ther; 1996 Oct 15; 60(4):368-73. PubMed ID: 8873684
    [No Abstract] [Full Text] [Related]

  • 27. Letter: Rauwolfia derivatives and breast cancer.
    Lancet; 1974 Oct 05; 2(7884):833. PubMed ID: 4138379
    [No Abstract] [Full Text] [Related]

  • 28. [Reserpine and breast neoplasms].
    Wedel H, Wilhelmsen L.
    Lakartidningen; 1975 Jan 22; 72(4):233-4. PubMed ID: 1121204
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Letter: Rauwolfia derivatives and cancer.
    Immich H.
    Lancet; 1974 Sep 28; 2(7883):774-5. PubMed ID: 4143029
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Hypotensive effects of fursemide, triamterene and reserpine combination in patients with essential hypertension on ambulatory care].
    Saldanha RV, Veras RO, de Paula e Silva P, de Serro-Azul LG.
    Rev Paul Med; 1971 Nov 28; 78(4):137-40. PubMed ID: 5164638
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [DCR-515 (Brinerdin) in ambulatory treatment of hypertension].
    Vorburger C, Weisser HJ, Nanzer A, Halpern A.
    Ther Umsch; 1970 Mar 28; 27(3):188-94. PubMed ID: 4985524
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.